MedPath

森淼(山东)药业有限公司

Ownership
-
Established
2017-11-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20249537
Approval Date
Dec 1, 2024
NMPA

Cefazolin Sodium for Injection

Product Name
注射用头孢唑林钠
Approval Number
国药准字H20244871
Approval Date
Sep 10, 2024
NMPA

Betahistine Hydrochloride Tablets

Product Name
盐酸倍他司汀片
Approval Number
国药准字H20243912
Approval Date
Jun 4, 2024
NMPA

Folic Acid Tablets

Product Name
叶酸片
Approval Number
国药准字H20243422
Approval Date
Mar 29, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.